France has banned online sales of nicotine substitutes, and limited sales in pharmacies.
The idea is to prevent a run on nicotine replacements, after a widely reported study from a Paris hospital found smokers were less likely to be admitted to hospital with COVID-19.
The theory is that nicotine, which attaches to cell receptors, blocks the virus from entering those cells.
French researchers plan to test nicotine patches on patients and health workers.
Visit Business Insider’s homepage for more stories.
France on Friday banned online sales of nicotine replacements — such as nicotine gum and patches — after a widely reported Paris study found smokers were less likely to admitted to hospital for COVID-19.
In a draft legal text published earlier this week, the government warned there could be a run on nicotine replacements thanks to the study. Pharmacies dispensing treatments for tobacco addiction must limit the amount they issue to an individual patient to a single month’s supply.See the rest of the story at Business Insider
Should you turn off your air-conditioning if someone is sick with coronavirus in your home? Here’s what you need to know.A leading disinfectant company urged people not to inject themselves with its products, hours after Trump said it might kill the coronavirus inside the human bodyNASA designed a cheap, simple ventilator to prevent shortages in case of a 2nd wave of COVID-19 infections
To discover more visit: feedproxy.google.com